ACP-196 (Acalabrutinib), a Novel Bruton Tyrosine Kinase (BTK) Inhibitor, for Treatment of Chronic Lymphocytic Leukemia, Richter's Syndrome or Prolymphocytic Leukemia
Acerta Pharma BV
Acerta Pharma BV
Acerta Pharma BV
Astellas Pharma Inc
Gilead Sciences
MedImmune LLC
Cellerant Therapeutics
AstraZeneca
INSYS Therapeutics Inc
MedImmune LLC